The supplementary appendix suggests that only ~ 50% of the patients were on a statin and less than < 50% were on antiplatelet in both arms. Arguments have been made that the good outcomes in ISCHEMIA and SCOT-HEART trials have been due to their good medical management. Although this study was executed before ischemia and scot-heart were published, I'm curious regarding the author's thoughts regarding whether the use of CCTA will lead to increase in statin/anti-platelet utilization.
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.